Page last updated: 2024-11-06

adamantanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Adamantanine is a synthetic adamantane derivative with potential therapeutic properties. It is structurally similar to amantadine, an antiviral drug used to treat influenza. Adamantanine exhibits antiviral activity against various viruses, including influenza, herpes simplex virus, and HIV. Its antiviral mechanism is believed to involve blocking the entry of the virus into host cells by interfering with viral protein interactions. Studies have also shown that adamantanine possesses neuroprotective effects, potentially through modulation of dopamine receptors and glutamate signaling. Its ability to cross the blood-brain barrier makes it a promising candidate for the treatment of neurodegenerative diseases, such as Parkinson's disease. However, further research is needed to evaluate its efficacy and safety in humans.'

adamantanine: inhibitor of amino acid transport; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64354
SCHEMBL ID544408
MeSH IDM0047330

Synonyms (27)

Synonym
BB 0253509
adamantanine
2-amino-2-adamantanecarboxylic acid
2-aminoadamantane-2-carboxylic acid
42381-05-5
nsc145160
nsc-145160
AKOS005264672
2-amino-adamantane-2-carboxylic acid
AKOS006239318
unii-f52g3frr68
nsc 145160
f52g3frr68 ,
FT-0678415
AM20070489
WQMQRNCPZFUGID-UHFFFAOYSA-N
SCHEMBL544408
DTXSID00195187
DS-5102
mfcd09264341
tricyclo(3.3.1.13,7)decane-2-carboxylic acid, 2-amino-
2-aminotricyclo(3.3.1.13,7)decane-2-carboxylic acid
A50283
A872896
2-aminoadamantane-2-carboxylicacid
CS-0079505
EN300-43496
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]